Special Issue "Advances in the Pathogenesis and Treatment of Immune-Mediated Inflammatory Diseases"
Deadline for manuscript submissions: closed (30 September 2021).
Interests: immune-mediated inflammatory diseases; molecular regulation of inflammation; signal transduction; B cells; dendritic cells; endothelial cells/angiogenesis
Interests: immune-mediated inflammatory diseases; molecular regulation of inflammation; lymphocytes; stromal cells; NF-κB signaling
This Special Issue will focus on the rapidly evolving field of immune-mediated inflammatory diseases (IMIDs) and the achievements that were made over the last 10 years. With the advent of novel technologies such as single-cell RNA sequencing and state-of-the-art imaging techniques, researchers in our field have made tremendous progress in unraveling the pathogenesis of autoimmune diseases such as rheumatoid arthritis, vasculitis, and systemic lupus erythematosus, as well as autoinflammatory diseases such as spondyloarthritis and fever syndromes. This has also provided new insights into the contribution of specific (subsets of) immune cells and stromal cells to the inflammatory response, as well as the molecular pathways associated with the pathological processes involved. These advances have led to the identification of promising new therapeutic targets for these diseases and paved the way for novel treatments. However, for rare IMIDs, we are far from fully understanding the underlying mechanisms leading to the development and progression of disease, as well as the response to therapy. A better understanding of the molecular and cellular signatures of these diseases may inform us about potential new treatment options that could be explored.
This Special Issue of IJMS will focus on the molecular, cellular, and clinical advances in the pathogenesis and treatment of IMIDs. We will consider original research, review, or methods manuscripts related to this subject and the keywords below.
Dr. Sander W. Tas
Dr. Jan Piet van Hamburg
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- immune cells
- stromal cells
- lymphoid organs
- inflammatory mediators
- signal transduction
- state-of-the-art technology, including (sc)RNAseq and (imaging)CyTOF
- molecular imaging and advanced microscopy
- animal models